Quantitative-imaging in Cardiac Transthyretin Amyloidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Quantitative-imaging in Cardiac Transthyretin Amyloidosis — Stella

Recruiting

Back to ATTR-CM trials

Trial locations(1 site)

Netherlands

University Medical Centre Groningen, Groningen

Key details

Sponsor

University of Edinburgh

Collaborators

British Heart Foundation, Netherlands Heart Foundation

Enrollment target

~140 participants

Started

August 2021

Primary completion

September 2026

Age range

40 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov